ATTOSCRIPTA Trademark Application Published for Opposition

ChangeBridge: Trademarks - Pharmaceuticals (Class 005)

Published March 26th, 2026

Detected March 27th, 2026

Summary

The USPTO has published the trademark application for 'ATTOSCRIPTA' for opposition. The application covers a wide range of research reagents, diagnostic preparations, and chemicals for scientific and industrial use, primarily within the pharmaceutical and biotechnology sectors. The publication opens a period for third parties to oppose the trademark registration.

View original document View source feed page

What changed

The United States Patent and Trademark Office (USPTO) has published the trademark application for 'ATTOSCRIPTA' (TM79444742) for opposition. This publication signifies that the application has passed initial examination and is now open to challenges from third parties who may believe the mark infringes on their existing rights. The application covers a broad scope of goods and services, including research preparations such as antibodies and nucleic acid probes, clinical research reagents, diagnostic assay reagents, aptamers, affinity reagents, and various chemical reagents for both medical research and industrial/scientific applications.

While this is a trademark publication and not a regulatory rule, it has implications for companies operating in the pharmaceutical, biotechnology, and chemical research sectors. Competitors or other interested parties have a defined period to file an opposition to the trademark registration. Companies considering using the 'ATTOSCRIPTA' mark or similar branding should be aware of this publication and the potential for opposition proceedings. The filing date for the application was November 19, 2025, and the publication date was March 26, 2026.

What to do next

Monitor trademark opposition proceedings for ATTOSCRIPTA (TM79444742).

Source document (simplified)

← USPTO Trademark Applications

ATTOSCRIPTA

Published for Opposition TM79444742 Kind: published Mar 26, 2026

Abstract

Research preparations, namely antibodies or nucleic acid probes, for the investigation of disease models; preparations for medical and veterinary research; reagents containing primary antibodies for research use; chemical reagents and medical preparations for research purposes; clinical research reagents; chemical reagents for medical or veterinary research purposes, namely reagents for immuno-histochemistry detection and in situ-hybridisation detection; in situ-hybridisation probes for medical research purposes; epitope retrieval solutions for medical research purposes; enzymes and enzyme preparations for medical research purposes; histological dye and stain solutions for medical research purposes; dewaxing and wash buffers used with the aforementioned preparations; fluorescent dyes and fluorescent labels for diagnostic use; assay reagents for diagnostic use; aptamers for diagnostic use; affinity reagents for diagnostic use; supramolecular host-guest systems for diagnostic use; reagents containing primary antibodies, aptamers, affimers, or other affinity reagents, nucleic acid probes, fluorescent dyes, fluorescent labels, non-optically detectable labels, blocking agents, inactivation agents for diagnostic use; kits comprising a combination of any of the aforesaid research reagents, preparations for medical and veterinary research, clinical research reagents, in situ-hybridisation probes, epitope retrieval solutions, enzymes and enzyme preparations, histological dyes and stain solutions, dewaxing and wash buffers, fluorescent dyes and fluorescent labels, assay reagents, aptamers, affinity reagents, supramolecular host-guest systems, reagents containing primary antibodies, affimers, or other affinity reagents, nucleic acid probes, non-optically detectable labels, blocking agents and inactivation agents, all for diagnostic and medical research purposes.; Chemicals for use in industry and science; chemical reagents for non-medical purposes; reagents for research purposes; research reagents and preparations, except for medical or veterinary use; research preparations used in science; chemical reagents and diagnostic preparations for use in research laboratories and for use in industry; fluorescent dyes and fluorescent labels for applications in industry and science; assay reagents for use in research, quality control, diagnostic use; aptamers for use in research, quality control; affinity reagents for use in research or quality control; supramolecular host-guest systems for use in research or quality control; reagents containing primary antibodies, aptamers, affimers, or other affinity reagents, nucleic acid probes, fluorescent dyes, fluorescent labels, non-optically detectable labels, blocking agents, inactivation agents for research use; kits comprising a combination of any of the aforesaid chemical reagents, research reagents and preparations, assay reagents, affinity reagents, supramolecular host-guest systems, nucleic acid probes, fluorescent dyes, fluorescent labels, non-optically detectable labels, blocking agents and inactivation agents, all for industrial, scientific and research use.